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Histopathology and selective biomarker expression in
human meibomian glands
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Abstract
Background/aims Meibomian gland dysfunction
(MGD) is the most common form of evaporative dry
eye disease, but its pathogenesis is poorly understood.
This study examined the histopathological features of
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MGD in humans.
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Methods Histological analyses was performed on the
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and Visual Sciences, Washington MGs in the tarsal plates dissected from four cadaver
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donors, two young and two old adults, including a
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36-year-old female (36F) and three males aged 30, 63
and 64 years (30M, 63M and 64M).
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Results The MGs of 36F displayed normal anatomy
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ductal obstruction with mild distortion. The obstruction
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with hyperproliferation, but not hyperkeratinisation. In
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two older males, moderate to severe MG atrophy was
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noted. Cell proliferation was significantly reduced in the
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MG acini of the two older donors as measured by Ki67
Accepted 21 September 2019
labelling index (6.0%±3.4% and 7.9%±2.8% in 63M
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and 64M, respectively) when compared with that of the
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two younger donors (23.2%±5.5% and 16.9%±4.8%
in 30M and 36F, respectively) (p<0.001). The expression
patterns of meibocyte differentiation biomarkers were
similar in the older and younger donors.
Conclusion Our histopathological study, based
on a small sample size, suggests potentially distinct
pathogenic mechanisms in MGD. In the young male
adult, hyperproliferation and aberrant differentiation of
the central ductal epithelia may lead to the obstruction
by overproduced cytokeratins. In contrast, in older adults,
decreased cell proliferation in acinar basal epithelia
could be a contributing factor leading to MG glandular
atrophy.

►► Additional material is
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please visit the journal online
(http://d x.doi.o rg/10.1136/
bjophthalmol-2019-314466).
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Meibomian glands (MGs), located in the upper
and lower tarsal plates of the eyelids, are holocrine
glands composed of secretory acini surrounding a
central duct.1 Based on their anatomical locations,
acinar epithelia cells are classified as basal (germinative or proliferative), differentiating, mature
and superficial degenerated cells. Each acinus at
its basal circumference comprises a single layer of
proliferative epithelial cells, which are essential for
acinar regeneration. When the basal cells start to
differentiate, they move inward and mature into
lipid-producing meibocytes. After reaching maturity, the meibocytes disintegrate as holocrine cells
and release lipids (meibum) into the short collecting

ductules that connect with the central secretory
duct lined by the squamous epithelial cells. Meibum
produced from the mature and decomposed meibocytes travels through the ductule to the central duct
and is discharged through the central duct and onto
the ocular surface via the MG orifice. The secreted
meibum constitutes the outermost layer of the
tear film, overlying the inner mucoaqueous layer
and providing tear film stability.2 Normal meibum
from healthy MGs forms a barrier against tear film
evaporation and protects the ocular surface from
microbial and environmental insults such as dust
and pollen.
Meibomian gland dysfunction (or disease; MGD)
is a term broadly used to encompass various functional abnormalities of MGs.3–5 Conventionally,
MGD can be classified as MG ductal obstruction, MG hyposecretion and MG hypersecretion.
MG ductal obstruction and hyposecretion are
more common than MG hypersecretion, which
is frequently associated with eyelid inflammation
and occurs in rosacea, chalazion and allergy.6–8
Animal models of MGD have shown that ductal
hyperkeratinisation can result in ductal obstruction,
meibum stasis, cystic dilation and, eventually, acinar
atrophy and MG dropouts.9 Keratinised materials,
however, are not normally present in the ducts of
human MGs.10 Compromised meibum quality is
another contributing factor to ductal obstruction.11
Studies in both animals and humans suggest that
acinar epithelial abnormalities, such as diminished
renewal of acinar basal cells and/or impaired meibocyte differentiation, contribute to the pathogenesis
of age-related MGD.12–14 Androgen deficiency and
medications, such as isotretinoin, are also thought
to play a role in MGD.15–17
The high prevalence of MGD and its diverse
pathology implicate that it is a multifactorial
disease,18 19 but the histopathological changes and
underlying molecular mechanisms of MGD have
not been extensively elucidated, which makes it
clinically challenging to diagnose and manage
MGD effectively. To gain a better understanding
of the pathogenesis of MGD, we performed
histopathological examinations and biomarker
expression analyses on MG tissues of four cadaver
donors, including two young adults and two older
adults. Our current study implies that fundamentally different pathogenic mechanisms underlie
MGD. Despite the limited sample size in this study,
our findings unveiled previously poorly described
pathogenic mechanisms of MGD and shed light
on potential avenues for the development of
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mechanism-
targeted diagnostic and therapeutic strategies for
MGD.

Materials and methods
Acquisition of donor tarsal tissues

Fresh tarsal tissues from four cadaver donors were obtained
from Mid-America Transplant (St. Louis, Missouri, USA). The
donors were free of known systemic illness and included two
young adults and two older adults: a 30-year-old male (30M),
a 36-year-old female (36F), a 63-year-old male (63M) and a
64-year-old male (64M). The medical and ocular histories of the
donors were deidentified prior to removal of the tarsal plates
from the inner upper eyelids of the fresh cadavers. The removal
of donor corneas and tarsal plates was performed by eye bank
staff under the standard protocol for procurement of ocular
tissues. The use of human tissues in research conformed to the
provisions of the Declaration of Helsinki and was exempted by
the Washington University Human Research Protection Office,
St. Louis, Missouri, USA.

Histology, immunofluorescence, immunohistochemistry and
quantification of cell proliferation

Human tarsal tissues were fixed overnight in 4% paraformaldehyde in phosphate-buffered saline (PBS) and then processed for
embedding in paraffin. Tissue sections (5 µm) were treated with
xylene; rehydrated in a decreased ethanol series; and subjected
to H&E staining, immunofluorescence or immunohistochemistry.20 For antigen retrieval of immunostaining, tissue sections
were boiled in 10 mM sodium citrate buffer for 10 min and then
cooled to room temperature. To block endogenous peroxidase
activity, sections were treated with 3% hydrogen peroxide in
PBS for 20 min. Tissue sections were blocked with 3% horse
serum in PBST (PBS plus 0.1% Tween-20) for 1 hour at room
temperature and then incubated overnight at 4°C with primary
antibodies diluted in the same buffer (table 1). Slides were
washed with PBS, incubated at room temperature for 1 hour
with either fluorophore-conjugated or biotinylated secondary
antibodies and then washed with PBS. For immunofluorescence,
cell nuclei were stained with 4′,6-diamidino-2-phenylindole
and slides were mounted with Mowiol (Sanofi-Aventis, Bridgewater, New Jersey, USA). For immunohistochemistry, sections
were incubated with Vectastain Elite ABC Reagent (PK-6100;
Vector Laboratories, Burlingame, California, USA) and colour
was developed by using 3,3′-diaminobenzidine as a substrate

Table 1
Protein

Sources and dilution ratios of primary antibodies
Company

Product catalogue
no

Dilution ratio

FASN

Santa Cruz

sc-48357

1:500

Ki67

Cell Signaling

9129

1:500

Krt1

Santa Cruz

Sc-65999

1:1000

Krt6a

BioLegend

905 701

1:5000

Krt10

Covance (BioLegend)

PRB-159P

1:1000

Krt14

Covance

PRB-155P

1:1000

Krt16

Novusbio

NBP2-45538

1:1000

Krt17

Novusbio

NBP2-16089

1:1000

p63

Santa Cruz

SC −25268

1:200

PCNA

Abcam Inc.

ab29

1:1000

PPARγ

Cell Signaling

2435

1:200

FASN, fatty acid synthase; PCNA, proliferating cell nuclear antigen; PPARγ,
peroxisome proliferator activated receptor gamma.

1000

Figure 1 Human MG in tarsal plate and histology in MG tissue from
four cadaver donors. (A–D) Tarsal plates dissected from cadavers’
eyelids, designated as 36F (A), 30M (B), 64M (C) and 63M (D), were
photographed directly before trimming off some of the orbicularis oculi
muscle. Note: The thickness of the dissected tissue and setting of the
photographic illumination gave rise to different appearance in tissue
transparency. The two older donors (C, D) showed moderate to severe
MG atrophy with glandular shortening (arrow in C) or dropout (arrow in
D). (E–H) Histology (H&E staining). The circumference of MG acinus (a)
in the 36F is made of a layer of basal epithelium that surrounds a cluster
of lipid (meibum)-producing meibocytes (E). In 30M (F), thickened ductal
epithelia (arrows in F) and hypercellularity were noted in the Cd. MGs
of the two older donors (G and H) exhibited fibrotic areas with MG
remnants (G’, arrowheads) and acinar atrophy (H, arrows). Scale bar
denotes 100 µm. 36F, 36-year-old female; 30M, 30-year-old male; 63M,
64-year old male; 64M, 64-year old male; a, acinus; Cd, central duct; d,
ductule; MG, meibomian gland.
(D4293; Sigma-Aldrich, St. Louis, Missouri, USA). Sections were
counterstained with haematoxylin for visualisation of cell nuclei.
Quantification of the cell proliferation was determined by Ki67
labelling index which is the ratio of Ki67-positive cells to the
total basal epithelial cells counted, and the data were presented
as means±SD. Unpaired t-tests were used to compare the Ki67
index among individual donors or between the younger age group
(30M and 36F) and the older age group (63M and 64M). A p
value of less than 0.001 was considered statistically significant.

Results
Histology of MGs in human cadaver donors

The MGs in the tarsal plates dissected from cadaver eyelids
were first examined for gross morphology (figure 1A–D). The
MGs of 36F were uniformly distributed in the tarsal plate and
acini were evenly sized and appeared normal (figure 1A). Mild
ductal distortion was observed in the MGs of 30M (figure 1B).
In the two older donors (63M and 64M), MG atrophy, including
glandular shortening and dropouts (arrows in figure 1C,D), was
readily visualised in tarsal tissues.
Histology revealed notable variations in the acinar and ductal
structure of MGs among the donors (figure 1E–H). In 36F, the
lipid-producing acini were connected to the central duct by short
branching ductules (figure 1E). By comparison, in 30M the MG
central ducts were thickened from epithelial hypercellularity
and filled with cellular debris and nuclear fragments (figure 1F,
arrows). Compared with the two younger donors (30M and
36F), the MG tissues of the two older donors (64M and 63M)
displayed altered features, with obliterated (figure 1G’) and
shrunken acini (figure 1H) scattered among areas containing
normal-appearing acini (figure 1G).

Ductal obstruction without increased keratinisation
biomarkers

Krt10 and its type II pair Krt1 are considered to be keratinisation
markers because they are expressed in terminally differentiated
Reneker LW, et al. Br J Ophthalmol 2020;104:999–1004. doi:10.1136/bjophthalmol-2019-314466
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of the 36F. Furthermore, the debris blocking the central duct of
30M did not stain positive for Krt10 (figure 2B, arrowhead).
Therefore, the Krt10/Krt1 expression pattern in 30M suggests
that hyperkeratinisation is unlikely to be the direct cause of
ductal obstructive MGD in this case.
The abnormal Krt10/Krt1 expression pattern in the central
duct of 30M prompted us to investigate the expression of Krt14,
a marker for basal cells in most epithelial tissues, including
the skin.21 In MGs of both 30M and 36F, Krt14 was highly
expressed in the acini and in the basal epithelium of the central
duct (figure 2E,F). However, in 30M, Krt14 expression was
found not only in the basal layer of the central duct but also in
multiple suprabasal layers (figure 2F inset). The abnormal and
expanded expression of Krt14 in the central ductal epithelia was
confirmed on multiple MGs from 30M and also by using cross
sections of MGs from this donor (data not shown). These results
suggest abnormal proliferation and differentiation of the central
ductal epithelia may cause ductal obstruction in this donor.

Figure 2 Expression of Krt10, Krt1 and Krt14 in MGs of the two
young donors, one with normal-appearing MGs (36F) and the other with
evidence of ductal obstruction (30M). (A,B) Krt10 was expressed in the
suprabasal layers of ductules and central duct in 36F (A, red arrows).
In the central duct of 30M, the Krt10-positive suprabasal layers (inset
in B, red arrow) was ‘sandwiched’ between two Krt10-negative layers,
presumably the basal layer (black arrow) and the superficial layer (open
arrow). Ductal blockage (arrowhead in B) was caused by Krt10-negative
proteins mixed with cell nuclear fragments. (C, D) Krt1 expression level
in the MGs of 36F and 30M was high in the ductules and reduced in the
suprabasal layer of the central duct (as indicated by arrows in C). Similar
to the Krt10 pattern seen in MGs of 30M (B), the superficial layer of the
central duct in this donor was negative for Krt1 (open arrows in D). (E,
F) Krt14 was highly expressed in the MG acinar and ductule epithelia
in both 36F (E) and 30M (F). Krt14 expression was limited to the basal
epithelium in the central duct in 36F (arrows in E). The thickness of the
Krt14-positive layer was notably increased in the central duct of 30M
(F, black arrow in the inset). Scale bar denotes 100 µm. 36F, 36-year-old
female; 30M, 30-year-old male; a, acinus; Cd, central duct; d, ductule;
MG, meibomian gland.
keratinocytes.21 To investigate whether hyperkeratinisation of
the ductal epithelia may account for the ductal obstruction in
30M, the expression patterns of Krt10 and Krt1 in MGs of the
four donors were examined. We first verified the respective specificity of anti-Krt10 and anti-Krt1 antibodies by confirming their
positive staining patterns at the mucocutaneous junction (MCJ)
of cadaver eyelids (online supplementary figure S1). Expression
of both Krt10 and Krt1 was interrupted at the MCJ where the
epidermal epithelium transitions into the conjunctival epithelium
(indicated by open arrows in online supplementary figure S1).
Krt10 and Krt1 expression patterns in MGs of 36F, 63M and
64M differed from those of 30M. In 36F, both Krt10 and Krt1
were present in the suprabasal layer of the collecting ductules
and the central duct (arrows in figure 2A,C). Similar patterns
were seen in the MGs of 64M and 63M (data not shown).
Interestingly, in the central duct of 30M, a Krt10/Krt1-positive
suprabasal layer (red arrow in figure 2B inset) was sandwiched
between the basal layer (black arrow) and a yet uncharacterised
Krt10/Krt1-negative superficial layer (figure 2D, open arrows).
The Krt10/Krt1-positive middle layer in the central duct of 30M
was not thicker than the corresponding layer in the central duct

Ductal obstruction from overproduction of cytokeratins
linked to hyperproliferation

Keratin 16 (Krt16) is typically expressed in stratified squamous
epithelia and certain glandular tissues.20–22 Overexpression of
Krt16 and its type II pair Krt6, along with Krt17 overexpression,
is associated with keratinocyte hyperproliferation and considered to be hallmarks for psoriasis, a chronic inflammatory skin
disease.23 24 To explore the role of these cytokeratins in MGD,
we examined the expression of keratins 16, 6a and 17 in the
MGs of 30M, 36F and 64M (figure 3).
In MGs of 36F and 64M, Krt16 was mostly expressed in the
ductules adjacent to the central duct, moderately expressed in
the acinar periphery and minimally expressed in the MG central
duct (figure 3A,C). In contrast, in the MG of 30M, Krt16 was
overexpressed in the central duct (figure 3B, top right inset) and
a ‘plug’, which was not stained by Krt16, was present in the
orifice (figure 3B, red arrow in bottom left inset). Similar to the
expression of Krt16, Krt6a expression in the MGs of 36F and
64M was greatest in the ductules adjacent to the central duct
but attenuated in the central duct (figure 3D,F). In contrast,
Krt6a was overexpressed in the central ducts of 30M (figure 3E),
consistent with the aforementioned Krt16 overexpression in this
young male donor.
Like Krt16 in psoriatic dermatitis, overexpression of Krt17
has been found in this disease.25 In our study of MGs, Krt17
was distributed in acinar and ductal epithelia more ubiquitously
than Krt16/Krt6a (figure 3G–I). The Krt17 level appeared to be
increased in the thickened central ducts of 30M, as compared with
Krt17 expression in the central ducts of 36F and 63M (compare
figure 3H with figure 3G,I). Taken together, the findings suggest
that overproduction of Krt16/Krt6a and Krt17 in the central ductal
epithelia of the 30M is likely the underlying or a contributing cause
of ductal obstruction in this younger male donor, who probably
had clinically undetected obstructive MGD.

Hyperproliferation and aberrant differentiation of central
ductal epithelia

Because overexpression of Krt16 and Krt17 is associated with
keratinocyte hyperproliferation, we examined the cell proliferation markers Ki67 and proliferating cell nuclear antigen (PCNA) in
central ductal epithelia and compared the levels in 30M and 36F
(figure 4A–D). Both Ki67- and PCNA-positive cells were markedly
increased in the basal epithelia of the central duct of 30M when
compared with the levels in the central duct of 36F. Furthermore,
the Ki67 labelling index in the MG ductal basal epithelia of 30M
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Figure 3 Expression of Krt16, Krt6a and Krt17 in MGs of an older
donor (64M) and of the two young donors, one with normal-appearing
MGs (36F) and the other with evidence of ductal obstruction (30M).
(A–C) Krt16 protein was mostly distributed in MG ductules and
decreased in the MG central duct of 36F (A) and 64M (C) as compared
with Krt16 expression in 30M (B). The central ductal cells in 30M
showed Krt16 overexpression (B, montage and inset on the top right)
and an orifice ‘plug’ (B, red arrow in bottom left inset). (D–F) Krt6a
expression was similar to Krt16 expression in the MG ductules of 36F
(D) and 64M (F). Krt6a overproduction was seen in the central duct of
30M (E). (G–I) Krt17 was ubiquitously expressed in the MGs of 30M,
36F and 64M, with a higher level in the epithelial cells of ductules.
Krt17 overexpression was noted in the central duct of 30M, but not in
the central duct of 36F and 64M (H). Scale bar denotes 100 µm. 36F,
36-year-old female; 30M, 30-year-old male; 64M, 64-year old male; a,
acinus; Cd, central duct; d, ductule; MG, meibomian gland.
was higher than that of 36F and 64M (p<0.001) (figure 4E). The
histopathology also showed that nuclear fragments were retained
in the thickened suprabasal layer of the central duct of 30M (red
arrows in figure 4B,D), suggesting the abnormal differentiation of
the ductal epithelia. These results together suggest that the potential cause of obstructive MGD in 30M is epithelial hyperproliferation with aberrant differentiation, associated with overproduction
of cytokeratins, leading to the accumulation of proteins and
nuclear debris in the central duct.

Age-related decline of acinar cell renewal and gland atrophy

Transcription factor p63 (TP63), a member of p53 family, is
expressed by proliferative stem cells or progenitor cells in several
stratified epithelia.26 27 We found p63 expression in the basal
epithelia of MG acini, the ductule and the central duct in MG
tissue of each donor (figure 5A,B and data not shown for 30M
and 64M), but p63 expression was reduced in some of the MG
basal acini of 63M (figure 5B, red ‘a’). When cell proliferation
marker Ki67 was colocalised with p63, Ki67-positive cells were
also notably decreased in the acini of 63M, as compared with
the number of Ki67-positive cells in the acini of 36F (compare
1002

Figure 4 Expression of cell proliferation markers in MGs of the donor
with ductal obstruction (30M), the donor with normal-appearing MGs
(36F) and one of the older donors (63M). (A, B) Ki67 expression. Ki67-
positive cells were rarely identified in the basal epithelia of the central
ducts in 36F (A). In contrast, many Ki67-positive cells were noted in the
basal epithelia of 30M (B, black arrows). (C, D) PCNA expression was
found in the nuclei of the acinar basal epithelium of 36F (C, arrow),
and expression was diminished in cells differentiating into meibocytes.
PCNA-expressing cells were rarely detected in the MG central duct
in 36F (C), whereas in 30M PCNA-positive cells were abundant in
the epithelia of the central duct (D, black arrow). In 30M, cell nuclear
fragments were retained in the superficial layer of the MG central
duct (B and D, red arrows). (E) Ki67 labelling index in MG ductal basal
epithelia. Cell proliferation rate in ductal basal epithelia was higher in
30M than in 36F and 63M (p<0.001). Scale bar denotes 100 µm. 36F,
36-year-old female; 30M, 30-year-old male; 63M, 63-year old male;
a, acinus; CD, central duct; D, ductile; MG, meibomian gland; PCNA,
proliferating cell nuclear antigen.

figure 5B with figure 5A). The Ki67 labelling index was significantly lower in the older group (6.0%±3.4% and 7.9%±2.8%
for 63M and 64M, respectively) than that in the younger group
(23.2%±5.5% and 16.9%±4.8% for 30M and 36F, respectively) (p<0.001) (figure 5C), suggesting that this decrease
of cell proliferation may compromise acinar cell renewal and
haemostasis in older individuals, leading to age-
related MG
atrophy (figure 1D).
The main function of MGs is to produce and secrete lipids
(meibum) that coat the outer tear film and prevent its evaporation.28 The expression patterns of the meibocyte differentiation markers, peroxisome proliferator activated receptor gamma
and fatty acid synthase, were compared between the 36F and
older (64M) donor, representing a young with normal-appearing
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Figure 5 Expression of cell proliferation and differentiation
biomarkers in MG acini of the 30-year-old, 36-year-old, 63-year-old and
64-year-old donors. (A, B) p63 (green nuclear staining) was expressed
in acinar (a) and ductal basal epithelia in the MGs of 36F (A) and 63M
(B). Notably fewer Ki67-positive cells (red nuclear staining pointed
by white arrows) were present in Mg acini of 63M acini (B), when
compared with those in 36F’s acini (A). Reduction of p63 expression
was noted in 63M (marked with red ‘a’ in B). (C) Bar graph depicting
the Ki67 labelling index in MG acinar basal epithelia. The proliferation
rate in basal acini was significantly higher in two younger donors (36F
and 30M) than in the two older donors (64M and 63M) (p<0.001).
(D–G) PPARγ expression (D and E, red arrows) and FASN expression
(F and G, black arrows) were relatively intense in newly differentiated
meibocytes and attenuated to background level in mature meibocytes
(D and E, open arrows) in both 36F and 64M. Scale bar denotes 100 µm.
36F, 36-year-old female; 30M, 30-year-old male; 63M, 63-year old male;
64M, 64-year old male; a, acinus; Cd, central duct; d, ductile; FASN, fatty
acid synthase; MG, meibomian gland; PPARγ, peroxisome proliferator
activated receptor gamma.
MGs and an older donor with age-related atrophy. The staining
patterns for these differentiation biomarkers were similar in
the MGs of 36F and 64M (figure 5D–G), suggesting that, in
this older donor’s acini where cell proliferation was reduced
(figure 5C), the expression of meibocyte differentiation markers
appeared to be normal.

Discussion

MGD is the major cause of evaporative dry eye disease and has
diverse aetiologies.3 18 29 Ductal obstruction and acinar or glandular atrophy are common features of MGD. To understand the
pathogenesis of MGD, it is of paramount importance to investigate the histopathological changes in human MGs. This study
describes the histological findings and the results of immunostaining for selective biomarkers in the MGs of cadaver tarsal
plate tissues from two donors in the fourth decade of life (young
age group) and two donors in the seventh decade of life (older
age group). Despite of limited sample size, the data shed light on
the notion that multiple pathogenic factors can contribute to the
development of MGD.
Hyperkeratinisation of ductal epithelia has been shown in
animal models of MGD to alter the structure and function of
MGs by plugging the MG central ducts, causing ductal dilation
and disruption of meibum excretion.9 10 Ductal plugs comprising

non-keratinised epithelial cells have also been observed in animal
models of MGD.12 30 In this current study of human MGs, the
tissue debris blocking the central ducts of 30M did not display
the typical characteristics of hyperkeratinisation (figures 2 and
3). In the MGs of this donor, the keratinisation biomarkers
Krt10 and Krt1 were present in the middle layer, above the
expressing basal layer, but underneath the superficial
Krt14-
layer of the central ductal epithelia. Based on this abnormal
expression pattern of the keratinisation biomarkers (Krt10 and
Krt1), an alternative mechanism other than hyperkeratinisation
seems likely to be the cause of ductal obstruction in this young
male adult.
We propose that hyperproliferation and aberrant differentiation of the central ductal epithelial cells led to MG ductal obstruction and plugging in 30M. This conclusion is supported by the
presence of overproduction of Krt6a/Krt16/Krt17 (figure 3) and
increased cell proliferation markers (figure 4). Besides ductal
obstruction, excessive cytokeratins are also disruptive to the
quality of meibum as well as the stability of the lipid layer in
the tear film. Meibum undergoes a maturation process as it is
secreted into the ductules, with protein removal and/or lipid
accumulation prior to excretion onto the ocular surface and
incorporation into the tear film.31 It has been shown that the
addition of purified cytokeratins to meibum lipid can affect the
fluidity of the meibum.32 Such an increase in the protein–lipid
ratio correlates with increased meibum viscosity.33 Thus, it is
conceivable that overproduction and retention of Krt6a/Krt16/
Krt17 in the central duct, as found in the MGs of 30M, could
have a profound effect on meibum quality and fluidity and lead
to MG obstruction and the eventual development of MGD.
MGD is often associated with certain skin diseases, such as
acne rosacea, atopic dermatitis, seborrhoeic dermatitis and
psoriasis.6 It was reported that patients with psoriasis vulgaris
have a high prevalence of obstructive MGD, characterised by
ductal plugging and impaired meibum secretion.34 In psoriatic
skin, the Krt6/Krt16 pair and Krt17, along with cell proliferation maker Ki67, are considered to be biomarkers for keratinocyte hyperproliferation.23 The pertinent medical record of the
30M prior to corneal and tarsal plate removal did not reveal any
indication of psoriatic skin lesions. Krt6 and Krt16 are known
as stress-
activated keratins.35 Our interesting findings in this
donor’s MGs imply a potential utility of Krt6a/Krt16 staining of
meibum excreta as diagnostic biomarkers to ascertain the diagnosis of obstructive MGD.
It is well documented that the process of ageing is associated
with a decrease in the number of MGs along with an increase in
MG dropouts.5 10 14 15 Postulated factors include age-mediated
hormonal changes, stem cell attenuation and growth factor deficiency. Other studies have demonstrated reduced Ki67 nuclear
staining in old murine and human MGs,5 14 which is consistent
with our current finding of a reduced number of Ki67-positive
cells in the acinar basal epithelia in MGs of 64M and 63M
(figure 5C). Furthermore, we found that p63, a transcription
factor for epithelial morphogenesis and stemness, was also
downregulated in some acini in the MGs of 63M (figure 5B).
Taken together, these observations suggest that a deficiency in
acinar basal cell proliferation and/or MG progenitor/stem cell
renewal may be a major contributing factor for the development
of age-related MGD. In searching for the endogenous regulators
responsible for MG cell renewal and homeostasis, we recently
found that fibroblast growth factor receptor 2 (FGFR2) is highly
expressed in both murine and human MGs. Using an inducible
conditional knockout mouse model, we have demonstrated
that FGFR2 signalling plays an essential role in MG acinar
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proliferation and renewal.20 Nevertheless, the significance of
FGFR2 and its ligands in human MG homeostasis awaits further
investigations.
In summary, while our study is limited by the small sample
size due to the poor availability of donor eyelids, the histopathological and biomarker analyses of MG tissues from a young
donor with normal-appearing MGs, a young donor with ductal
obstruction and two donors in their early 60s shed insights into
the diverse underlying pathogenic mechanisms of MGD. The
findings of our study suggest that ductal epithelial hyperproliferation and abnormal differentiation, without notable hyperkeratinisation, can lead to MG obstruction, as in the case of 30M,
whereas a decline in acinar cell proliferation and renewal is more
likely the underlying cause of age-related MG atrophy, as in the
two older donors. The findings also suggest that overexpression
of hyperproliferative keratins in meibum may serve as potential
biomarkers to diagnose specific type of obstructive MGD.
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